The active ingredient in Baxter International’s widely used blood-thinning drug heparin, which had been pulled after being tied to at least four deaths and 350 illnesses, was made in a Chinese factory that wasn’t inspected by the U.S. Food and Drug Administration. There is no conclusive link between the Chinese plant and the drug’s safety problems, but the disclosure added to concerns over Chinese-made goods and the FDA’s ability to ensure the safety of the U.S. drug supply. (The Wall Street Journal)